These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


507 related items for PubMed ID: 23932451

  • 21. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S, Yenjai C, Waiwut P, Vajragupta O, Reubroycharoen P, Tohda M, Boonyarat C.
    Eur J Med Chem; 2014 Mar 21; 75():21-30. PubMed ID: 24508831
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.
    Chao X, He X, Yang Y, Zhou X, Jin M, Liu S, Cheng Z, Liu P, Wang Y, Yu J, Tan Y, Huang Y, Qin J, Rapposelli S, Pi R.
    Bioorg Med Chem Lett; 2012 Oct 15; 22(20):6498-502. PubMed ID: 22981331
    [Abstract] [Full Text] [Related]

  • 24. Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.
    Jiang H, Wang X, Huang L, Luo Z, Su T, Ding K, Li X.
    Bioorg Med Chem; 2011 Dec 01; 19(23):7228-35. PubMed ID: 22041172
    [Abstract] [Full Text] [Related]

  • 25. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
    Huang L, Miao H, Sun Y, Meng F, Li X.
    Eur J Med Chem; 2014 Nov 24; 87():429-39. PubMed ID: 25282266
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease.
    Luo Z, Liang L, Sheng J, Pang Y, Li J, Huang L, Li X.
    Bioorg Med Chem; 2014 Feb 15; 22(4):1355-61. PubMed ID: 24461494
    [Abstract] [Full Text] [Related]

  • 27. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F, Rampa A, Piazzi L, Bisi A, Gobbi S, Bartolini M, Andrisano V, Cavalli A, Recanatini M, Valenti P.
    J Med Chem; 2005 Jun 30; 48(13):4444-56. PubMed ID: 15974596
    [Abstract] [Full Text] [Related]

  • 28. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
    Rouleau J, Iorga BI, Guillou C.
    Eur J Med Chem; 2011 Jun 30; 46(6):2193-205. PubMed ID: 21435752
    [Abstract] [Full Text] [Related]

  • 29. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y, Qiang X, Li Y, Yang X, Luo L, Xiao G, Cao Z, Tan Z, Deng Y.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):2035-9. PubMed ID: 26947607
    [Abstract] [Full Text] [Related]

  • 30. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
    Skibiński R, Czarnecka K, Girek M, Bilichowski I, Chufarova N, Mikiciuk-Olasik E, Szymański P.
    Chem Biol Drug Des; 2018 Feb 15; 91(2):505-518. PubMed ID: 28944565
    [Abstract] [Full Text] [Related]

  • 31. Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
    Nerella A, Jeripothula M.
    Bioorg Med Chem Lett; 2021 Oct 01; 49():128212. PubMed ID: 34153471
    [Abstract] [Full Text] [Related]

  • 32. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
    Fernández-Bachiller MI, Pérez C, Monjas L, Rademann J, Rodríguez-Franco MI.
    J Med Chem; 2012 Feb 09; 55(3):1303-17. PubMed ID: 22243648
    [Abstract] [Full Text] [Related]

  • 33. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.
    Wu W, Liang X, Xie G, Chen L, Liu W, Luo G, Zhang P, Yu L, Zheng X, Ji H, Zhang C, Yi W.
    Molecules; 2018 Oct 05; 23(10):. PubMed ID: 30301153
    [Abstract] [Full Text] [Related]

  • 34. Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Liao S, Deng H, Huang S, Yang J, Wang S, Yin B, Zheng T, Zhang D, Liu J, Gao G, Ma J, Deng Z.
    Bioorg Med Chem Lett; 2015 Apr 01; 25(7):1541-5. PubMed ID: 25724825
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. 2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies.
    Mohamed T, Rao PPN.
    Eur J Med Chem; 2017 Jan 27; 126():823-843. PubMed ID: 27951490
    [Abstract] [Full Text] [Related]

  • 37. Design, synthesis, biological evaluation and docking study of 5-oxo-4,5-dihydropyrano[3,2-c]chromene derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Khoobi M, Alipour M, Sakhteman A, Nadri H, Moradi A, Ghandi M, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2013 Oct 27; 68():260-9. PubMed ID: 23988409
    [Abstract] [Full Text] [Related]

  • 38. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
    Liu HR, Liu XJ, Fan HQ, Tang JJ, Gao XH, Liu WK.
    Bioorg Med Chem; 2014 Nov 01; 22(21):6124-33. PubMed ID: 25260958
    [Abstract] [Full Text] [Related]

  • 39. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB, Palaka BK, Penumala M, Kotapati KV, Devineni SR, Eadlapalli S, Darla MM, Ampasala DR, Vadde R, Amooru GD.
    Eur J Med Chem; 2016 Jan 01; 107():219-32. PubMed ID: 26588065
    [Abstract] [Full Text] [Related]

  • 40. Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's.
    Sun ZQ, Tu LX, Zhuo FJ, Liu SX.
    Bioorg Med Chem Lett; 2016 Feb 01; 26(3):747-750. PubMed ID: 26783181
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.